AMWL

American Well Corp
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$209.89M
P/E Ratio
EPS
$-4.74
Beta
1.70
52W High
$14.19
52W Low
$3.71
50-Day MA
$10.33
200-Day MA
$6.67
Dividend Yield
Profit Margin
-35.70%
Forward P/E
PEG Ratio

About American Well Corp

American Well Corporation is a telehealth business enabling digital healthcare delivery. The company is headquartered in Boston, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$218.53M
Gross Profit (TTM)$114.91M
EBITDA$-39.89M
Operating Margin-19.60%
Return on Equity-29.10%
Return on Assets-12.70%
Revenue/Share (TTM)$13.25
Book Value$13.07
Price-to-Book0.96
Price-to-Sales (TTM)0.96
EV/Revenue0.086
EV/EBITDA-0.81
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-26.60%
Shares Outstanding$15.36M
Float$11.82M
% Insiders5.32%
% Institutions50.72%

Historical Volatility

HV 10-Day
124.76%
HV 20-Day
96.23%
HV 30-Day
105.79%
HV 60-Day
86.24%
HV Rank
100.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($12.80 target)
1
Buy
6
Hold

Latest News

Amwell makes grant to new employees under inducement plan

BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwell made grants of RSUs covering an aggregate of 6,679 shares of its Class A common stock to two new non-executive employees. The grants were offered as material inducement to the employees' entry into employment with Amwell.

GlobeNewsWire8/7/2026Neutral
American Well Q2 Earnings Call Highlights

American Well NYSE: AMWL, which operates as Amwell, reported second-quarter 2026 revenue of $52 million, down 26.6% from a year earlier, while narrowing its adjusted EBITDA loss and raising its full-year profitability outlook as the company pursues operating and cash-flow breakeven in the fourth quarter.

MarketBeat8/5/2026Positive
Amwell® Announces Results for the Second Quarter 2026

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026. “The DHA's intent to make Amwell a prime contractor is a powerful endorsement of our platform and our people,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell.

GlobeNewsWire8/4/2026Neutral
Amwell® to report second quarter 2026 operating results

BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results after stock market trading hours on Tuesday, August 4. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.

GlobeNewsWire7/24/2026Neutral
American Well (AMWL) Moves 9.4% Higher: Will This Strength Last?

American Well (AMWL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research6/29/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMWL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026